Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer

ABSTRACT: Randomized Single-blind Placebo-controlled Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer, With Different Doses and Regimens

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2210827 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR